NZ513739A - Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer - Google Patents

Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer

Info

Publication number
NZ513739A
NZ513739A NZ513739A NZ51373900A NZ513739A NZ 513739 A NZ513739 A NZ 513739A NZ 513739 A NZ513739 A NZ 513739A NZ 51373900 A NZ51373900 A NZ 51373900A NZ 513739 A NZ513739 A NZ 513739A
Authority
NZ
New Zealand
Prior art keywords
mage
cdna
cloning
diagnosis
cancer
Prior art date
Application number
NZ513739A
Other languages
English (en)
Inventor
Alfonso Serrano
Bernard Lethe
Christophe Lurquin
Plaen Etienne De
Donata Rimoldi
Thierry Boon-Falleur
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of NZ513739A publication Critical patent/NZ513739A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ513739A 1999-03-02 2000-03-01 Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer NZ513739A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26097899A 1999-03-02 1999-03-02

Publications (1)

Publication Number Publication Date
NZ513739A true NZ513739A (en) 2001-09-28

Family

ID=22991462

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ513739A NZ513739A (en) 1999-03-02 2000-03-01 Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer

Country Status (7)

Country Link
EP (1) EP1194542A1 (ko)
JP (1) JP2003512814A (ko)
KR (1) KR20020011967A (ko)
AU (1) AU3389500A (ko)
CA (1) CA2366059A1 (ko)
NZ (1) NZ513739A (ko)
WO (1) WO2000052163A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007053956A1 (en) 2005-11-14 2007-05-18 Universite Laval Cancer antigen mage-a9 and uses thereof
WO2019007974A1 (en) 2017-07-07 2019-01-10 Immatics Biotechnologies Gmbh NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NSCLC, CPPC AND OTHER CANCERS
CR20210168A (es) 2017-07-07 2021-06-10 Immatics Biotechnologies Gmbh Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de pulmón, incluyendo el nsclc, el sclc y otros cánceres
FR3087448B1 (fr) 2018-10-23 2023-10-13 Pdc Line Pharma Lignee pdc modifiee pour secreter une cytokine
TW202039535A (zh) 2018-12-18 2020-11-01 德商英麥提克生物技術股份有限公司 B*08限制肽和肽組合物抗癌免疫治療和相關方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
US5612201A (en) * 1991-05-23 1997-03-18 Ludwig Institute For Cancer Research Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor

Also Published As

Publication number Publication date
EP1194542A1 (en) 2002-04-10
KR20020011967A (ko) 2002-02-09
CA2366059A1 (en) 2000-09-08
AU3389500A (en) 2000-09-21
JP2003512814A (ja) 2003-04-08
WO2000052163A1 (en) 2000-09-08

Similar Documents

Publication Publication Date Title
HK1042084A1 (en) Substituted benzimidazoles and their preparation and use.
ZA200007040B (en) Catalyst modifiers and their use in the polymerization of olefin(s).
EP1076090A2 (en) ESTs and encoded human proteins
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
GB9903841D0 (en) Diagnosis and treatment of cancer
GB0106183D0 (en) Improvements in or relating to the treatment of lesions
HK1047134A1 (zh) 用於乳腺癌治療和診斷的組合物及其應用方法
HUP0402489A3 (en) 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
WO1999029729A3 (en) Antagonists of neuropilin receptor function and use thereof
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
AU4923200A (en) Isothiazolecarboxamides and their use as microbicides
IL206604A (en) Protein @ trans @membrane @@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@ @@
AU2001250978A1 (en) Polynucleotides and polypeptides, their use in diagnosis and treatment of cardiac, renal or inflammary disease
HK1031725A1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
ZA97741B (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
HK1063629A1 (en) 3,7-Diazabicyclo Ä3.3.0Üoctanes and their use in the treatment of cardiac arrhythmias
EP1210416A4 (en) GENES CODING PROTEINS FOR DIAGNOSTIC, PREVENTIVE AND THERAPEUTIC USE
EP1208191A4 (en) 13 PROTEINS ASSOCIATED WITH COLON CANCER AND HUMAN COLON
HUP0201997A3 (en) Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
IL160018A0 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
HUP0003811A3 (en) Oxyranyle-triazoline thiones, their preparation and their use as microbicides
AU2890199A (en) Gata-3-expression in human breast carcinoma
HK1042504A1 (en) Human cervical cancer 1 protooncogene and protein encoded therein
NZ513739A (en) Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer
AU5618700A (en) Extracellular camp-dependent protein kinase in diagnosis, prognosis and treatment of cancer

Legal Events

Date Code Title Description
AVOD Application void